DUOLAC, Cell Biotech’s probiotic brand widely recognized as the “221x stronger probiotic,” has successfully concluded its ‘Focus Seminar 2025,’ held nationwide across 16 regions from February to November this year. A total of 32 sessions were conducted, drawing 1,000 pharmacists in attendance and reaffirming DUOLAC’s credibility and influence as a pharmacy-based professional brand. For over 30 years, Cell Biotech has focused exclusively on the research and development of Korean-origin...

Cell Biotech’s flagship probiotic brand DUOLAC, known for its robust and scientifically validated strains, has launched ‘DUOLAC Gold D-Drops,’ a pharmacy-exclusive probiotic designed specifically for newborns. The new product is a premium oil-based probiotic drop formulation that incorporates DUOLAC’s proprietary technology and uses only carefully selected strains that have been registered as GRAS by the U.S. FDA and validated through human clinical trials, ensuring a high level of safety....

Cell Biotech has, for the first time, identified the mechanism by which its patented probiotic strain CBT-LR5 (KCTC 12202BP)—used in major products of the DUOLAC brand—improves cognitive impairment in an animal model. This study provides new scientific evidence supporting the gut–brain axis  theory, which posits that gut health affects brain health. The findings were published in the SCI(E)-indexed international journal Frontiers in Microbiology (IF 4.5). Cell Biotech developed the...